“Clinical evidence of prospective randomized study catapulted Liberty into high quality trifocal group of IOLs available on the market.”
E. Van Acker, MD(Belgium)
“
“After over 100 implantations trifocal performance is evident. Less halos & glare, better contrast sensitivity. All my patients implanted with Liberty are spectacle independent.”
J. Győri, MD(Hungary)
“
“Exceptionally good platform and an optic that generates more patient satisfaction in terms of defocus curves and percieved dysphotopsia symptoms. I would not change a thing about this IOL.”
